BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 14, 2014
View Archived Issues
Academic team divulges novel FimH inhibitors
Read More
VolitionRx enters into agreement with University of Oxford for endometriosis diagnostic
Read More
Radboud University Medical Center wins NuGEN award for sarcoma genomics research
Read More
Medgenics and CHOP collaborate on pediatric rare and orphan genetic diseases
Read More
Enterome and AbbVie establish microbiome collaboration in Crohn's disease
Read More
Glionova Therapeutics raises financing for clinical development of glioblastoma candidate
Read More
BioCardia to conduct phase III trial of autologous bone marrow cell therapy for heart failure
Read More
GenomeDx and Mayo Clinic collaborate on expanded use of prostate cancer test
Read More
FDA approves supplemental NDAs for Invega Sustenna
Read More
First-in-human results for GSK-2878175 in healthy volunteers and patients with HCV
Read More
Advaxis submits IND for phase I/II study of ADXS-HPV and MEDI-4736 for HPV-related cancers
Read More
Phase II study of masitinib in hepatocellular cancer recommended to continue by DSMB
Read More
Safety and pharmacokinetic results for first-in-class HBV core inhibitor NVR-3-778
Read More
Suppression of Bcl-xL in hepatocellular carcinoma cells by TPU-0014
Read More
Presage expands cancer research agreement with Takeda
Read More
Arrien Pharmaceuticals patent details novel dual ITK/JAK3 inhibitors
Read More
Innocrin Pharmaceuticals to participate in phase II trial of VT-464 in prostate cancer
Read More
New lead candidates for broad-spectrum antimalarial drugs presented
Read More
University of Queensland developing new vaccine technology for polio
Read More
Japanese researchers describes anti-NLRR-1 MAbs
Read More
Merck & Co. presents preliminary phase I results for recombinant dengue vaccine
Read More
Janssen licenses Geron's imetelstat
Read More
Quatsomes EGF formulation developed to treat diabetic foot ulcers
Read More
Clinical trials of favipiravir and brincidofovir planned in Ebola virus outbreak region
Read More
Mitsubishi Tanabe seeks Japanese approval of Radicut for ALS
Read More